Accelerating Clinical Trials in the European Union (ACT-EU)
The Multistakeholder Platform (MSP) and the position of the European Industrial Pharmacists Group (EIPG) by Rebecca Rebecca Stanbrook…
The first Union list of critical medicines
by Giuliana Miglierini The first version of the Union list of critical medicines was published on 12 December…
The drug shortage situation – EIPG’s point of view
by Maurizio Battistini The shortage of medicines has been a major concern in the countries of the European…
EMA’s reflection paper on AI in the pharmaceutical lifecycle
by Giuliana Miglierini The rapidly evolving role of artificial intelligence (AI) and its possible application in the pharmaceutical…
EMA’s recommendations to prevent medicines shortages
By Giuliana Miglierini Continuity of medicinal product supply is still representing a key issue for European countries. The…
ACT EU’s Workplan 2022-2026
by Giuliana Miglierini The implementation phase of the Accelerating Clinical Trials in the EU (ACT EU) initiative, launched…